$205.58
+6.29
(+3.16%)
As of Oct 15, 2026, 12:52 AM EDT
Price history
Today's analyst average
Analyst average over timeIndividual analyst targets
Analyst history starts Jul 30, 2026, the first target we tracked for PM.
Philip Morris International (PM) is trading up at $205.58 (+3.16%) on NYSE/NASDAQ, as of the latest quote. It is a S&P 500 constituent in the Consumer Staples sector.
Analyst price targets on PM
One firm's current price target on Philip Morris International: $225 — 9% above the current $206. Each is tracked to its date and scored the same way a member's call is.
- Citi $192 → $225 by Jul 2027 Jul 30, 2026 via marketbeat.com · Citi's track record
Targets published by research firms, extracted from the news, checked against independent reporting, and linked to their source. Where a firm did not state a horizon the target is tracked as 12 months, the industry convention; the rows where the firm set its own horizon are marked. Reported here as facts about what was published — not recommendations from Dalsna Finance, and no firm listed is affiliated with this site.
Philip Morris International revenue & net income history (FY2016–FY2025)
RevenueNet incomeNet margin (right axis, %)
| FY2016Dec 2016 | FY2017Dec 2017 | FY2018Dec 2018 | FY2019Dec 2019 | FY2020Dec 2020 | FY2021Dec 2021 | FY2022Dec 2022 | FY2023Dec 2023 | FY2024Dec 2024 | FY2025Dec 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $75.0B | $78.1B | $29.6B | $29.8B | $28.7B | $31.4B | $31.8B | $35.2B | $37.9B | $40.6B |
| Growth (year over year) | +1.4% | +4.2% | −62.1% | +0.6% | −3.7% | +9.4% | +1.1% | +10.7% | +7.7% | +7.3% |
| Gross profit | $17.3B | $18.3B | $18.9B | $19.3B | $19.1B | $21.4B | $20.4B | $22.3B | $24.5B | $27.3B |
| Gross margin | 23.1% | 23.5% | 63.7% | 64.7% | 66.7% | 68.1% | 64.1% | 63.3% | 64.8% | 67.1% |
| Operating income | $10.9B | $11.6B | $11.4B | $10.5B | $11.7B | $13.0B | $12.2B | $11.6B | $13.4B | $14.9B |
| Operating margin | 14.5% | 14.8% | 38.4% | 35.3% | 40.7% | 41.3% | 38.6% | 32.9% | 35.4% | 36.6% |
| Net income | $6.97B | $6.04B | $7.91B | $7.18B | $8.06B | $9.11B | $9.05B | $7.81B | $7.06B | $11.3B |
| Net margin | 9.3% | 7.7% | 26.7% | 24.1% | 28.1% | 29.0% | 28.5% | 22.2% | 18.6% | 27.9% |
| EPS (diluted) | $4.48 | $3.88 | $5.08 | $4.61 | $5.16 | $5.83 | $5.81 | $5.02 | $4.52 | $7.26 |
| Balance sheet | ||||||||||
| Cash and equivalents | $4.24B | $8.45B | $6.59B | $6.86B | $7.28B | $4.50B | $3.21B | $3.06B | $4.22B | $4.87B |
| Total assets | $36.9B | $43.0B | $39.8B | $42.9B | $44.8B | $41.3B | $61.7B | $65.3B | $61.8B | $69.2B |
| Total liabilities | $47.8B | $53.2B | $50.5B | $52.5B | $55.4B | $49.5B | $68.0B | $74.8B | $71.7B | $77.2B |
| Long-term debt | $25.9B | $31.3B | $27.0B | $26.7B | $28.2B | $24.8B | $34.9B | $41.2B | $42.2B | $45.1B |
| Shareholders' equity | −$12.7B | −$12.1B | −$12.5B | −$11.6B | −$12.6B | −$10.1B | −$8.96B | −$11.2B | −$11.8B | −$9.99B |
| Cash flow | ||||||||||
| Operating cash flow | $8.08B | $8.91B | $9.48B | $10.1B | $9.81B | $12.0B | $10.8B | $9.20B | $12.2B | $12.2B |
| Capital expenditure | $1.17B | $1.55B | $1.44B | $852.0M | $602.0M | $748.0M | $1.08B | $1.32B | $1.44B | $1.57B |
| Free cash flow | $6.91B | $7.36B | $8.04B | $9.24B | $9.21B | $11.2B | $9.73B | $7.88B | $10.8B | $10.7B |
| Dividends paid | $6.38B | $6.52B | $6.88B | $7.16B | $7.36B | $7.58B | $7.81B | $7.96B | $8.20B | $8.62B |
| Share buybacks | $0 | $0 | — | $0 | $0 | $775.0M | $209.0M | $0 | $0 | — |
RevenueNet incomeNet margin (right axis, %)
| Q3 FY24Sep 2024 | Q4 FY24†Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25†Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $9.91B | $9.71B | $9.30B | $10.1B | $10.8B | $10.4B | $10.1B | $11.2B |
| Growth (year over year) | +8.4% | +7.3% | +5.8% | +7.1% | +9.4% | +6.8% | +9.1% | +10.4% |
| Gross profit | $6.54B | $6.28B | $6.27B | $6.87B | $7.36B | $6.79B | $6.91B | $7.66B |
| Gross margin | 66.0% | 64.7% | 67.4% | 67.7% | 67.8% | 65.5% | 68.1% | 68.4% |
| Operating income | $3.65B | $3.26B | $3.54B | $3.71B | $4.26B | $3.37B | $3.89B | $4.53B |
| Operating margin | 36.9% | 33.6% | 38.1% | 36.6% | 39.3% | 32.6% | 38.4% | 40.5% |
| Net income | $3.08B | −$579.0M | $2.69B | $3.04B | $3.48B | $2.14B | $2.44B | $2.82B |
| Net margin | 31.1% | −6.0% | 28.9% | 30.0% | 32.1% | 20.7% | 24.0% | 25.2% |
| EPS (diluted) | $1.97 | −$0.37 | $1.72 | $1.95 | $2.23 | $1.36 | $1.56 | $1.80 |
| Balance sheet | ||||||||
| Cash and equivalents | $4.26B | $4.22B | $4.44B | $4.14B | $4.04B | $4.87B | $5.45B | $6.00B |
| Total assets | $66.9B | $61.8B | $65.1B | $68.5B | $67.1B | $69.2B | $68.9B | $68.3B |
| Total liabilities | $74.6B | $71.7B | $74.0B | $78.5B | $76.0B | $77.2B | $76.2B | $74.9B |
| Long-term debt | $44.2B | $42.2B | $38.8B | $42.4B | $41.9B | $45.1B | $43.8B | $42.4B |
| Shareholders' equity | −$9.69B | −$11.8B | −$10.9B | −$12.0B | −$10.9B | −$9.99B | −$9.28B | −$8.58B |
| Cash flow | ||||||||
| Operating cash flow | $3.34B | $4.00B | −$350.0M | $3.41B | $4.46B | $4.71B | −$399.0M | $5.49B |
| Capital expenditure | $379.0M | $278.0M | $404.0M | $356.0M | $365.0M | $444.0M | $353.0M | $380.0M |
| Free cash flow | $2.96B | $3.72B | −$754.0M | $3.06B | $4.10B | $4.26B | −$752.0M | $5.11B |
| Dividends paid | $2.03B | $2.11B | $2.12B | $2.11B | $2.11B | $2.29B | $2.31B | $2.30B |
From Philip Morris International's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. Net margin is our own calculation from those reported figures (net income ÷ revenue); it is left blank where revenue is zero or missing. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →
About Philip Morris International
Philip Morris International Inc. (PMI) is a American publicly traded tobacco company, with products sold in over 180 countries. Marlboro is PMI’s most recognized brand, but in the last quarter of 2023, Iqos generated the greatest revenue. Philip Morris International is often referred to as one of the companies comprising Big Tobacco. The company ranked No. 117 in the 2025 Fortune 500 list of the largest US corporations by total revenue.
Source: Wikipedia — Philip Morris International
- Headquarters
- Stamford, Connecticut From SEC filings, Oct 2026
Recent News (20)
-
Philip Morris shares fell after six consecutive sessions of losses Philip Morris shares fell after six consecutive sessions of losses TradingView
-
Philip Morris shares fall after six consecutive sessions of gains Philip Morris shares fall after six consecutive sessions of gains TradingView
-
-
Intel, Philip Morris among market cap stock movers on Thursday
Intel, Philip Morris among market cap stock movers on Thursday
-
Connecticut Foodshare and PMI U.S. Join Forces to Support Connecticut Families Facing Food Insecurity Volunteers help prepare and distribute essential food supplies for Connecticut families facing food insecurity. STAMFORD, Conn., Sept. 30, 2026 /PRNewswire/ -- Connecticut Foodshare today announced co…
-
Philip Morris’ Dividend Gets an 8.8% Boost: What Investors Should Know
Philip Morris’ Dividend Gets an 8.8% Boost: What Investors Should Know
-
Philip Morris raises quarterly dividend 8.8% to $1.60 per share
Philip Morris raises quarterly dividend 8.8% to $1.60 per share
-
Trump surgeon general nominee discloses tobacco, pharma investments President Trump’s surgeon general nominee reported investments in the tobacco company Philip Morris International as well as beverage companies Monster Beverage Corp., Coca Cola Co. and Pepsi Co., acc…
-
PMI U.S. Expands ZYN Portfolio to Offer Adults More Smoke-Free Choices Broader range of strengths, flavors, and formats is designed to help legal-age adult nicotine consumers find an option that fits their preferences STAMFORD, Conn., Sept. 9, 2026 /PRNewswire/ -- The U.…
-
Philip Morris Raises FX Outlook as IQOS, ZYN Fuel Smoke-Free Growth
Philip Morris Raises FX Outlook as IQOS, ZYN Fuel Smoke-Free Growth
-
Philip Morris International at Barclays conference: smoke-free push stays on track Philip Morris International at Barclays conference: smoke-free push stays on track
-
FDA Authorization Expands Philip Morris’s Zyn Bet, Can It Pay Off?
FDA Authorization Expands Philip Morris’s Zyn Bet, Can It Pay Off?
-
-
I've Been Wrong About Philip Morris International Stock for 5 Years. Here's Why I'm Finally Changing My Mind.
I've Been Wrong About Philip Morris International Stock for 5 Years. Here's Why I'm Finally Changing My Mind.
-
Where Are the Bold Ideas Building America's Future? PMI U.S. Launches National Challenge to Find Out. "Community Futures Challenge" to Find and Fund Nonprofits Applying Local Ingenuity to Address America's Most Pressing Needs STAMFORD, Conn., Sept. 1, 2026 /PRNewswire/ -- Philip Morris International's…
-
Altria vs. Philip Morris: What the New Manufacturing Deal Means for Investors
Altria vs. Philip Morris: What the New Manufacturing Deal Means for Investors
-
Altria, Philip Morris International sign contract manufacturing deals
Altria, Philip Morris International sign contract manufacturing deals
-
-
PM Stock Alert: What to Know as Philip Morris Teams Up With Altria on Manufacturing
PM Stock Alert: What to Know as Philip Morris Teams Up With Altria on Manufacturing
-
FDA authorizes 11 ZYN Ultra nicotine pouches for Philip Morris
FDA authorizes 11 ZYN Ultra nicotine pouches for Philip Morris
More Consumer Staples stocks
- MNST Monster Beverage
- MO Altria
- PEP PepsiCo
- PG Procter & Gamble
- SJM J.M. Smucker Company (The)
- STZ Constellation Brands
- SYY Sysco
- TGT Target Corporation